Sou Hu Cai Jing·2025-07-22 03:13Core Viewpoint - The medical device sector is showing strong performance and resilience amidst market fluctuations, with significant investment interest and potential for growth driven by supportive policies and market dynamics [1][3]. Group 1: Market Performance - The medical device index ETF (159898) has recorded four consecutive days of gains, indicating strong market interest and a potential for further upward movement [1]. - Over the past three trading days, the ETF has attracted over 11 million in capital, signaling a clear initiation of investment interest [1]. Group 2: Policy Support - A significant policy, "Measures to Optimize Lifecycle Supervision to Support High-end Medical Device Innovation," was released in July, aimed at enhancing the development of high-end medical devices, including medical robots and AI medical devices [3]. - This policy is expected to streamline approval processes and shorten the profit cycle for companies, potentially matching or exceeding the support seen in the innovative drug sector [3]. Group 3: Domestic Market Opportunities - The announcement by a major player to reject imports of high-end medical devices over 45 million creates a substantial market opportunity for domestic manufacturers, particularly in high-end imaging and artificial organ sectors [6]. - The medical device index ETF covers key domestic companies that are likely to benefit from this shift towards domestic production [6]. Group 4: Market Trends and Projections - Historical data indicates that the medical device sector typically experiences a "front low, back high" performance pattern, with significant revenue growth expected in the third quarter as orders convert into income [8]. - Projections suggest that the overall market size for medical device bidding in China will exceed 80 billion in the first half of 2025, reflecting a year-on-year growth of over 60% [8].